Logo image
Improved magnetic delivery of cells to the trabecular meshwork in mice
Journal article   Peer reviewed

Improved magnetic delivery of cells to the trabecular meshwork in mice

M Reza Bahrani Fard, Jessica Chan, Gabriela Sanchez Rodriguez, Marybeth Yonk, Shreya R Kuturu, A Thomas Read, Stanislav Y Emelianov, Markus H Kuehn and C Ross Ethier
Experimental eye research, Vol.234, 109602
09/2023
DOI: 10.1016/j.exer.2023.109602
PMCID: PMC10530071
PMID: 37488007
url
https://pmc.ncbi.nlm.nih.gov/articles/PMC10530071/pdf/nihms-1921456.pdfView
Open Access

Abstract

Glaucoma is the leading cause of irreversible blindness worldwide and its most prevalent subtype is primary open angle glaucoma (POAG). One pathological change in POAG is loss of cells in the trabecular meshwork (TM), which is thought to contribute to ocular hypertension and has thus motivated development of cell-based therapies to refunctionalize the TM. TM cell therapy has shown promise in intraocular pressure (IOP) control, but existing cell delivery techniques suffer from poor delivery efficiency. We employed a novel magnetic delivery technique to reduce the unwanted side effects of off-target cell delivery. Mesenchymal stem cells (MSCs) were labeled with superparamagnetic iron oxide nanoparticles (SPIONs) and after intracameral injection were magnetically steered towards the TM using a focused magnetic apparatus (“point magnet”). This technique delivered the cells significantly closer to the TM at higher quantities and with more circumferential uniformity compared to either unlabeled cells or those delivered using a “ring magnet” technique. We conclude that our point magnet cell delivery technique can improve the efficiency of TM cell therapy and in doing so, potentially increase the therapeutic benefits and lower the risk of complications such as tumorigenicity and immunogenicity.

Details

Metrics

9 Record Views
Logo image